Federal Project Grant Award Summary

Duke University's Office of Research Administration was awarded $490,000 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year project beginning September 1, 2026, and concluding August 31, 2029. The project, titled "Genotype-Phenotype Modeling of Rare Sinonasal Tumors to Enable Precision Oncology," will deliver research services focused on developing computational and analytical models to correlate genetic characteristics with observable disease phenotypes in rare sinonasal tumors. This work supports the DHA's mission to advance medical solutions and innovative research addressing health conditions affecting Service Members and the broader military population through investigator-initiated basic and applied biomedical research.

The research outputs from this project will contribute to precision oncology approaches for rare sinonasal cancers, with the work performed at Duke University's Durham, North Carolina facility. As a leading research institution with demonstrated expertise in oncology research and biomedical innovation, Duke University will leverage its multidisciplinary capabilities and state-of-the-art research infrastructure to deliver the scientific findings and methodological advances needed to support military medical research priorities in rare cancer investigation.